Fumarates: Clinical Trials

1 trial of Fumarates, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Fumarates: new trials by email Literature Review of Fumarates trials Research Report on Fumarates

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq, Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod - Multiple Sclerosis, Relapsing-Remitting
Not applicableCompletedJohns Hopkins University9002018-05-022026-09-23

Conditions studied

Multiple Sclerosis, Relapsing-Remitting (1)

Sponsors

Johns Hopkins University (1)

Countries

United States (1)

Top investigators

Ellen M. Mowry, MD, MCR (1)  ·  Scott D. Newsome, DO (1)

Results publications

PMID 38654416